PFIZER INC — Director's Dealing 2019

Mar 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2019-02-28

Reporting Person: Fonseca Lidia (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-28	Common Stock	A	47510.0000	$0.0000	Acquired	47510.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-28	Stock Appreciation Rights	$43.3500	A	48736.0000	Acquired	2024-02-28	Common Stock (48736.0000)	Direct
2019-02-28	Stock Appreciation Rights	$43.3500	A	41071.0000	Acquired	2026-02-28	Common Stock (41071.0000)	Direct

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.